What We Do
How We Drive Success
Expertise and Innovation
Unmatched Expertise: Causal inference, real-world data, and operational delivery.
Integrated Approach: An evidence framework to optimize decisions across the drug development lifecycle.
Strategic & Operational Excellence
Data-Driven Strategies: Know-how to align clinical outcomes with commercial objectives.
Operational Excellence: Ability to design large-scale real-world evidence programs with precision and efficiency.
Solutions
Real World Data
Advice
RWD generation planning and fit for purpose assessment for regulatory and market access purposes.​​
​
​
Complex RWE Design
& Execution
Design and emulation of target trials.
External control arm planning, design and development.​​
​
Advisory on Emerging
Technologies
Guidance on adopting new technologies or methodologies.​​
​​
​​
​
Indication Prioritization and Portfolio Strategies
Proprietary IPPS™ framework to assess how to position the asset across the disease spectrum.
Strategic Development Plans & Market Access Strategies
Aligning drug development, market access, and regulatory strategies.
​
Partnership and Collaboration
Facilitation
Establishing collaboration, including with Key Opinion Leaders to advance drug development.
Real World Data
Clinical Insights Through
Global Real-World Data
To support regulatory decisions in rare or complex conditions, we advocate the use of clinically-rich real-world data. By tapping into these extensive datasets, our clients gain insights that drive their decisions from the inception of their products, facilitating a strategic advantage as they develop their assets.
In rare diseases, we have access to a unique data set allowing us to deliver global rare disease cohorts quickly and cost effectively.
​
